CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-14 | POLAN MARY LAKE PH D Director | Exercise or conversion · Restricted Stock Units (Premium) | −262 | 0 | ||
| 2023-05-14 | Michael Edward L. Director | Grant or award | +1,137 | 10,235 | ||
| 2023-05-14 | Michael Edward L. Director | Grant or award | +341 | 10,576 | ||
| 2023-05-14 | Michael Edward L. Director | Exercise or conversion · Restricted Stock Units (Converted) | −1,137 | 0 | ||
| 2023-05-14 | Michael Edward L. Director | Exercise or conversion · Restricted Stock Units (Premium) | −341 | 0 | ||
| 2023-05-14 | BUECHLER KENNETH F Director | Grant or award | +1,617 | 71,905 | ||
| 2023-05-14 | BUECHLER KENNETH F Director | Grant or award | +485 | 72,390 | ||
| 2023-05-14 | BUECHLER KENNETH F Director | Exercise or conversion · Restricted Stock Units (Converted) | −1,617 | 0 | ||
| 2023-05-14 | BUECHLER KENNETH F Director | Exercise or conversion · Restricted Stock Units (Premium) | −485 | 0 | ||
| 2023-04-01 | Iskra Michael S. EVP & CCO | Grant or award | +15,825 | 16,082 | ||
| 2023-04-01 | Iskra Michael S. EVP & CCO | Shares withheld for taxes | −6,930 | $89.09 | $617K | 9,152 |
| 2023-04-01 | Iskra Michael S. EVP & CCO | Exercise or conversion · Restricted Stock Units | −15,825 | 0 | ||
| 2023-03-31 | Dilsaver Evelyn S Director | Grant or award | +68 | 549 | ||
| 2023-03-31 | Dilsaver Evelyn S Director | Exercise or conversion · Restricted Stock Units | −68 | 0 | ||
| 2023-03-28 | Kroll Werner SVP, Research & Development | Grant or award · Restricted Stock Units | +11,433 | 11,433 | ||
| 2023-03-28 | Iskra Michael S. EVP & CCO | Grant or award · Non-Qualified Stock Option | +14,775 | 14,775 | ||
| 2023-03-28 | Iskra Michael S. EVP & CCO | Grant or award · Restricted Stock Units | +14,775 | 14,775 | ||
| 2023-03-28 | Hodges Michelle A. SVP, General Counsel | Grant or award · Non-Qualified Stock Option | +7,386 | 7,386 | ||
| 2023-03-28 | Hodges Michelle A. SVP, General Counsel | Grant or award · Restricted Stock Units | +7,388 | 7,388 | ||
| 2023-03-28 | Busky Joseph M Chief Financial Officer | Grant or award · Non-Qualified Stock Option | +14,775 | 14,775 |
Page 36 of 50 · 990 trades